{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:26:24Z","timestamp":1791285984390,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T00:00:00Z","timestamp":1377475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,7,10]]},"DOI":"10.1038\/onc.2013.351","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T14:09:05Z","timestamp":1377698945000},"page":"3748-3752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma"],"prefix":"10.1038","volume":"33","author":[{"given":"A","family":"Tallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Renier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Hysi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Galateau-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Copin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Andujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Le Pimpec-Barthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Jaurand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,26]]},"reference":[{"key":"BFonc2013351_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10937404.2011.556051","volume":"14","author":"SX Huang","year":"2011","unstructured":"Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK . Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B 2011; 14: 179\u2013245.","journal-title":"J Toxicol Environ Health B"},{"key":"BFonc2013351_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5858\/arpa.2011-0039-RA","volume":"136","author":"B Jasani","year":"2012","unstructured":"Jasani B, Gibbs A . Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med 2012; 136: 262\u2013267.","journal-title":"Arch Pathol Lab Med"},{"key":"BFonc2013351_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011; 43: 1022\u20131025.","journal-title":"Nat Genet"},{"key":"BFonc2013351_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","volume":"136","author":"D Jean","year":"2012","unstructured":"Jean D, Daubriac J, Le Pimpec-Barthes F, Galateau-Salle F, Jaurand MC . Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med 2012; 136: 277\u2013293.","journal-title":"Arch Pathol Lab Med"},{"key":"BFonc2013351_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668\u2013672.","journal-title":"Nat Genet"},{"key":"BFonc2013351_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrg2763","volume":"11","author":"AJ Cesare","year":"2010","unstructured":"Cesare AJ, Reddel RR . Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 2010; 11: 319\u2013330.","journal-title":"Nat Rev Genet"},{"key":"BFonc2013351_CR7","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1158\/1078-0432.CCR-08-0099","volume":"14","author":"R Villa","year":"2008","unstructured":"Villa R, Daidone MG, Motta R, Venturini L, De Marco C, Vannelli A et al. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res 2008; 14: 4134\u20134140.","journal-title":"Clin Cancer Res"},{"key":"BFonc2013351_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.lungcan.2010.12.023","volume":"73","author":"AY Au","year":"2011","unstructured":"Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC et al. Telomerase activity in pleural malignant mesotheliomas. Lung Cancer 2011; 73: 283\u2013288.","journal-title":"Lung Cancer"},{"key":"BFonc2013351_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/thx.53.11.915","volume":"53","author":"K Dhaene","year":"1998","unstructured":"Dhaene K, Hubner R, Kumar-Singh S, Weyn B, Van Marck E . Telomerase activity in human pleural mesothelioma. Thorax 1998; 53: 915\u2013918.","journal-title":"Thorax"},{"key":"BFonc2013351_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00000478-200203000-00011","volume":"26","author":"F Kumaki","year":"2002","unstructured":"Kumaki F, Kawai T, Churg A, Galateau-Salle FB, Hasleton P, Henderson D et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol 2002; 26: 365\u2013370.","journal-title":"Am J Surg Pathol"},{"key":"BFonc2013351_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1139\/o11-037","volume":"89","author":"M Gladych","year":"2011","unstructured":"Gladych M, Wojtyla A, Rubis B . Human telomerase expression regulation. Biochem Cell Biol 2011; 89: 359\u2013376.","journal-title":"Biochem Cell Biol"},{"key":"BFonc2013351_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 339: 959\u2013961.","journal-title":"Science"},{"key":"BFonc2013351_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA . Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 339: 957\u2013959.","journal-title":"Science"},{"key":"BFonc2013351_CR14","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA Jr. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 2013; 110: 6021\u20136026.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013351_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ijc.2910550331","volume":"55","author":"L Zeng","year":"1993","unstructured":"Zeng L, Buard A, Monnet I, Boutin C, Fleury J, Saint-Etienne L et al. In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines. Int J Cancer 1993; 55: 515\u2013520.","journal-title":"Int J Cancer"},{"key":"BFonc2013351_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ajpath.2010.10.039","volume":"178","author":"D Jean","year":"2011","unstructured":"Jean D, Thomas E, Manie E, Renier A, de Reynies A, Lecomte C et al. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol 2011; 178: 881\u2013894.","journal-title":"Am J Pathol"},{"key":"BFonc2013351_CR17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","volume":"133","author":"AN Husain","year":"2009","unstructured":"Husain AN, Colby TV, Ordonez NG, Krausz T, Borczuk A, Cagle PT et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133: 1317\u20131331.","journal-title":"Arch Pathol Lab Med"},{"key":"BFonc2013351_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1349-7006.2008.00815.x","volume":"99","author":"Y Cao","year":"2008","unstructured":"Cao Y, Bryan TM, Reddel RR . Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 2008; 99: 1092\u20131099.","journal-title":"Cancer Sci"},{"key":"BFonc2013351_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.gene.2012.01.095","volume":"498","author":"M Daniel","year":"2012","unstructured":"Daniel M, Peek GW, Tollefsbol TO . Regulation of the human catalytic subunit of telomerase (hTERT). Gene 2012; 498: 135\u2013146.","journal-title":"Gene"},{"key":"BFonc2013351_CR20","first-page":"639","volume":"10","author":"M Ramael","year":"1995","unstructured":"Ramael M, Van den Bossche J, Buysse C, Deblier I, Segers K, Van Marck E . Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura. Histol Histopathol 1995; 10: 639\u2013643.","journal-title":"Histol Histopathol"},{"key":"BFonc2013351_CR21","first-page":"23","volume-title":"The Pleura in Health and Disease","author":"NS Wang","year":"1985","unstructured":"Wang NS . Mesothelial cells in situ. In: Chr\u00e9tien JB J, Hirsch A (eds). The Pleura in Health and Disease. Marcel Dekker, New York, NY, USA, 1985, pp 23\u201342."},{"key":"BFonc2013351_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1440-1843.2002.00404.x","volume":"7","author":"SE Mutsaers","year":"2002","unstructured":"Mutsaers SE . Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7: 171\u2013191.","journal-title":"Respirology"},{"key":"BFonc2013351_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.intimp.2013.04.003","volume":"16","author":"XH Shen","year":"2013","unstructured":"Shen XH, Xu SJ, Jin CY, Ding F, Zhou YC, Fu GS . Interleukin-8 prevents oxidative stress-induced human endothelial cell senescence via telomerase activation. Int Immunopharmacol 2013; 16: 261\u2013267.","journal-title":"Int Immunopharmacol"},{"key":"BFonc2013351_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1083\/jcb.201210040","volume":"199","author":"NJ Ganem","year":"2012","unstructured":"Ganem NJ, Pellman D . Linking abnormal mitosis to the acquisition of DNA damage. J Cell Biol 2012; 199: 871\u2013881.","journal-title":"J Cell Biol"},{"key":"BFonc2013351_CR25","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.4161\/cc.4.12.2300","volume":"4","author":"C Lecomte","year":"2005","unstructured":"Lecomte C, Andujar P, Renier A, Kheuang L, Abramowski V, Mellottee L et al. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Cell Cycle 2005; 4: 1862\u20131869.","journal-title":"Cell Cycle"},{"key":"BFonc2013351_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lungcan.2009.03.018","volume":"67","author":"P Andujar","year":"2010","unstructured":"Andujar P, Wang J, Descatha A, Galateau-Salle F, Abd-Alsamad I, Billon-Galland MA et al. p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer 2010; 67: 23\u201330.","journal-title":"Lung Cancer"},{"key":"BFonc2013351_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/mutage\/get008","volume":"28","author":"P Andujar","year":"2013","unstructured":"Andujar P, Pairon JC, Renier A, Descatha A, Hysi I, Abd-Alsamad I et al. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma. Mutagenesis 2013; 28: 321\u2013323.","journal-title":"Mutagenesis"},{"key":"BFonc2013351_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.semcancer.2011.10.005","volume":"21","author":"LG Larsson","year":"2011","unstructured":"Larsson LG . Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol 2011; 21: 367\u2013376.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2013351_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2012; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFonc2013351_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1474-9726.2010.00599.x","volume":"9","author":"AV Bazarov","year":"2010","unstructured":"Bazarov AV, Van Sluis M, Hines WC, Bassett E, Beliveau A, Campeau E et al. p16(INK4a)-mediated suppression of telomerase in normal and malignant human breast cells. Aging Cell 2010; 9: 736\u2013746.","journal-title":"Aging Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013351","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:09:49Z","timestamp":1647889789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,26]]},"references-count":30,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2014,7,10]]}},"alternative-id":["BFonc2013351"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.351","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,26]]},"assertion":[{"value":"2 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}